Facing an Uphill Battle Together at The Pharma Anti-Counterfeiting & Brand Protection Summit

Philadelphia, PA (Feb 14) IQPC’s Pharma Anti-Counterfeiting & Brand Protection Summit, the nation’s foremost event addressing innovative solutions to manage and create your brand security strategy  will take place at the Hilton Garden Inn City Center, Philadelphia, this March 26-28 2017.

This summit will focus on key themes at the forefront of news today, such as learning how to protect your brand and collaborate with service providers, ensuring good manufacturing practices to avoid medicines being substandard, falsified, and unsafe, and incorporating cost-efficient ways to attain and secure regulatory compliance.

Our Distinguished Speakers Include:

• Andrew Zebrak, Executive Director, Government Affairs and Public Policy, Boehringer-Ingelheim Pharmaceuticals Inc
• Milton A. Tyrrell, Supervisory Special Agent (Unit Chief), Drug Enforcement Administration
• John Burke, President, International Health Facility Diversion Association
• Ravi Kalyanaraman, Associate Director, Bristol-Myers Squibb
• Aaron Graham, Executive Director Brand Safety & Security, Boehringer-Ingelheim Pharmaceuticals Inc
• Joseph Buerger, Brand Protection Technologies Manager, Takeda Pharmaceuticals
• Gregory Bylo, VP Healthcare, GS1 US
• David G. Howell, Director – Brand Protection, Vorys, Sater, Seymour and Pease LLP
• Kevin MacLachlan, Manager, Global Security Operations Center, Mylan

The Pharma Anti-Counterfeiting & Brand Protection Summit will bring together key opinion leaders from Mylan, Bristol-Myers, DEA, Takeda Pharmaceuticals, and moreto help you combat the ever-evolving technological threats to your product.

To access the full agenda or to register, visit https://anticounterfeitingpharma.iqpc.com/

“Pharma Anti-Counterfeiting and Brand Protection is expanding to include strategies for a complete brand protection strategy. Guarding your supply chain is no longer enough. Fortifying your cyber presence and protecting your intellectual property are key! Anti-counterfeiters are more advanced than ever with their opportunities, in a world of growing population and therefore medicines, constantly growing. Attendees can look forward to a comprehensive overview of how to put together a complete brand protection strategy and hear about the latest news related to the opioid crisis from the DEA themselves. ,” said Paulina Naroznik, Program Director for Pharma Anti-Counterfeiting and Brand Protection Summit.

IQPC is the organizer of the event and is collaborating with the Pharma IQ. Other partners include STAT News, American Pharmaceutical Review, Pharmaceutical Outsourcing, INCOPRO, Brady Solutions and more!

CONTACT:
Tiffany Lee

Pharma Anti-Counterfeiting & Brand Protection Summit
Tel: 212-885-2660
Email: Tiffany.Lee@iqpc.com